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Background: The World Health Organization (WHO) recommends parasitologic confirmation of suspected malaria
cases before treatment. Due to the limited availability of quality microscopy services, this recommendation has
become scalable following increased use of antigen-detecting malaria rapid diagnostic tests (RDTs) in many
malaria-endemic countries. This study was carried out to monitor quality of RDT performance in selected health
facilities using two quality assurance (QA) methods: reference microscopy and detection of parasite DNA by
real-time quantitative polymerase chain reaction (qPCR) on dried blood spots (DBS).
Methods: Blood samples for QA were collected from patients undergoing RDT for diagnostic confirmation of
malaria during two to three consecutive days per month in 12 health facilities in rural Tanzania. Stained blood
smears (BS) were first examined at the district hospitals (BS1) and then at a reference laboratory (BS2). Discordant
BS1 and BS2 results prompted a third examination. Molecular analysis was carried out at the Ifakara Health Institute
laboratory in Bagamoyo.
Results: Malaria RDTs had a higher positivity rate (6.5%) than qPCR (4.2%) or microscopy (2.9% for BS1 and 2.5% for
BS2). Poor correlation was observed between RDT and BS results: BS1 (K = 0.5), BS2 (K = 0.43) and qPCR (K = 0.45),
challenging the utility of these tests for RDT QA. In addition, many challenges related to qPCR processing were
recorded and long delays in obtaining QA test results for both microscopy and qPCR.
Conclusions: Overall there was limited agreement among the three diagnostic approaches and neither microscopy
nor qPCR appear to be good QA options for RDTs under field conditions.
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The 2012 World Malaria Report identified tremendous
achievements toward reduction of the global malaria burden
[1]. Success has mainly been attributed to increased cover-
age of malaria control interventions such as use of
insecticide-treated mosquito bed-nets (ITNs), indoor re-
sidual spraying (IRS), and use of effective treatments with
artemisinin-based combination therapy (ACT). In 2010, the* Correspondence: imasanja@ihi.or.tz
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unless otherwise stated.World Health Organization (WHO) recommended parasi-
tologic confirmation of suspected malaria cases before initi-
ating anti-malarial treatment [2] and many malaria endemic
countries in sub-Saharan Africa have adopted this policy
[3,4]. The scale-up of antigen-detecting malaria rapid diag-
nostic tests (RDTs) for Plasmodium species forms a vital
part of the strategy to confirm malaria infection prior to
treatment in resource-poor settings [5].
Laboratory confirmation of malaria is being achieved, in
part, due to the increased use of RDTs. With increased
testing, the effect of incorrect test results is becoming a
challenge in clinical management of patients suspected tol. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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rich protein (HRP)-2 based RDTs demonstrated a sensitivity
and specificity of over 90% for Plasmodium falciparum at
parasite densities over 200 parasites/μL [8], particularly in la-
boratory or controlled settings. However, later studies have
demonstrated that RDT sensitivity varied greatly between
health facilities in Tanzania (18.8% to85.9%), with data diffi-
cult to interpret due to poor microscopy slide quality from
some facilities [9]. Likewise other studies have reported sig-
nificant variations in RDT sensitivity and specificity [10-13]
and particularly when RDTs are exposed to adverse condi-
tions, such as higher temperature [14].
Among the earlier recommendations of WHO was to
assess performance of RDTs through periodic comparison
of RDT results to reference microscopy [15]. In this rec-
ommendation, each health facility using RDTs was ex-
pected to submit blood smears from twenty RDT positive
and twenty RDT negative patients monthly for evaluation
[15]; however, in the wake of changing malaria transmis-
sion patterns this may not be feasible in areas of low trans-
mission, as they may not have 20 positive RDTs in a
month. Additionally, challenges of obtaining good quality
blood smear results from lower level health facilities for
further assessment at reference laboratories have been re-
ported [16-19]. A need for a practical quality assurance
(QA) procedure for RDTs was apparent.
Tanzania’s Ministry of Health and Social Welfare through
the National Malaria Control Programme (NMCP) began to
deploy RDTs in 2010 in selected regions as a way to expand
and strengthen malaria diagnostic capacity throughout the
country. The NMCP recognized this effort to deploy RDTs
would require a suitable QA method that could be adopted
nationwide. The Ifakara Health Institute (IHI) in collabor-
ation with the US Centers for Disease Control and Preven-
tion (CDC) Malaria Branch and the U.S. President’s Malaria
Initiative (PMI), undertook a study in early 2010 to assess
two methods of RDT QA and their timeliness. This ap-
proach included comparison of RDT used in routine care of
patients, to reference microscopy and to a real-time quanti-
tative PCR (qPCR) assay.
Methods
Tanzania adopted a phased approach to the scale-up of
RDTs and first introduced the tests in three regions: Iringa
(low endemicity), Kagera (high endemicity) and Pwani
(high endemicity) in 2009. All levels of healthcare facilities
(hospital, health center, and dispensary) were targeted to
receive RDTs. These three regions accounted for approxi-
mately 12.8% of the Tanzania mainland’s estimated 41.9
million population in 2010 [20].
Study locations
A convenience sample of 12 health facilities with high
utilization rates in Iringa Region were selected to participatein this study; six in Mufindi District (Mafinga District
Hospital, Kibao Health Center, Usokami Health Center,
Malangali Health Center, Igomaa Dispensary and Sadani
Dispensary) and six in Iringa Rural District (Tosamaganga
Designated District Hospital, Idodi Health Center, Kimande
Health Center, Mlowa Dispensary, Ifunda Dispensary and
Ilambilole Dispensary). The selection was intended to in-
clude facilities in all levels of care: primary (dispensary), sec-
ondary (health center) and referral (district hospital).
Sample collection
RDT services were available for routine clinical care to all
study facilities. To perform a test, health worker obtained
finger-prick capillary blood specimens from patients sus-
pected to have acute malaria infection. The blood was col-
lected in a transfer device (either a capillary tube or loop)
and placed in the appropriate well on the RDT where it is
absorbed by the nitrocellulose paper. From the same fin-
ger prick an additional 2–3 drops of blood for a thick
blood smear (BS) and 2–4 drops of blood for a dried blood
spot (DBS) were collected. QA study samples were col-
lected for a two to three day period each month, during
the 5 months of data collection.
Training
Each facility received training on how to appropriately col-
lect, label and store specimens. Health workers at all partici-
pating facilities were trained to perform RDTs by the local
district council health management team (CHMT) during
the national RDT roll out in 2009. In addition, all techni-
cians at each district hospital laboratory had recently under-
gone a comprehensive microscopy competency training at
the National Institute for Medical Research headquarters,
Dar es Salaam, under the Walter Reed Army Institute of Re-
search programme [21].
The RDTs used in this evaluation were those available at
the government facilities through the Ministry of Health
and Social Welfare and included SD Bioline®, ParaHIT® and
Paracheck® obtained through the existing national procure-
ment and distribution system. Log books and unique ID
stickers were provided to record RDT results and for speci-
men tracking.
Supervision, specimen processing, and QA logistics
Study facilities received monthly visits from the district QA
supervisor (a laboratory technician). Once a month, two
days prior to the arrival of the supervisor, thick BS and DBS
were collected from all suspected malaria patients receiving
routine RDT at the health facility. A sticker was placed in
the log book where RDT results were recorded. At the facil-
ity, the QA supervisor collected 40 BS/DBS pairs prepared
in the previous two days, selecting pairs at random if greater
than 40 were available. BS samples were sent directly to the
district laboratory technician, who was blinded to RDT
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boratory, each BS was stained using 10% Giemsa solution
buffered to pH 7.2, and stained for 8–15 minutes. When a
dilution of 5% was used, staining was done for 30 minutes.
All BS together with the corresponding DBS were sent to
the IHI Bagamoyo laboratory for examination by a second
microscopist (BS2), blinded to RDT and BS1 results. For
both BS1 and BS2, a blood smear was declared negative
after reading 100 high power fields. Parasites were counted
in reference to 200 white blood cells. Any discordant results
between BS1 and BS2 were resolved by a third microscopist
(BS3), a senior technician from the Muhimbili University of
Health and Allied Sciences (MUHAS).
qPCR assays
DBS samples were processed and analysed using qPCR in
the IHI’s research laboratory located in Bagamoyo, Pwani
(qPCR1). As a validation, a subset of samples was retested
at CDC, Atlanta, GA (qPCR2). DNA was extracted from
DBS samples using a QIAamp DNA Mini Kit (QIAGEN,
Valencia, CA (Qiagen method)). The DNA was aliquoted
and stored at −20°C until used. For quantification, a 10-
fold serial dilution of P. falciparum (3D7) was prepared at
the Malaria Branch laboratory, CDC, Atlanta, GA and sent
to IHI, Bagamoyo. Briefly, parasites were cultured on an
orbital shaker to facilitate one parasite per red blood cell
infection. The culture was synchronized by the sorbitol
method to select for ring stage parasites which can repro-
ducibly be used for quantification of DNA. The parasite
density in parasites/μL was determined. Ten-fold dilutions
of the parasite culture were prepared with parasite dens-
ities ranging from 200,000 parasites/μL to 20 parasites/μL.
DNA was extracted from each dilution using the QIAamp
DNA Mini Kit. All qPCR assays were performed using
commercially available PCR buffer and taq polymerase
(New England Biolabs, Ipswich, MA). Primers and a HEX-
labeled Taqman probe to the P. falciparum beta-tubulin
gene were designed and used as previously described [22].
DNA amplification was carried out following the cycling
conditions: 95°C for 5 minutes, followed by 50 cycles of
95°C for 20 seconds and 58°C for 1 minute using the
Mx3005p real-time PCR machine (Agilent technologies).
The serially diluted 3D7 DNA standard was run in each
experiment and was used to estimate the parasite density
in the field samples. All samples were tested in triplicate.
A thousand DNA samples were sent to CDC from which
about 300 samples were systematically selected by picking
every 3rd sample. These were processed by qPCR as de-
scribed above and results used to validate the qPCR1 re-
sults from Bagamoyo.
Data processing and analysis
Data were entered in Microsoft Access (Microsoft Corpor-
ation, Microsoft Way- Redmond, Washington) and analyzedin STATA 11 (StataCorp, College Station, Texas). Only sam-
ples with a parasite density of 200 parasites/μL as deter-
mined by qPCR1, were considered as positives in the
comparison analysis, as this is considered the potential limit
of detection for RDTs [23]. Samples with negative qPCR1
results were included as negatives and samples with low-
density infection (<200 parasites/μL) by qPCR1 were ex-
cluded from analysis. Proportions of positive tests were
compared across the two districts and against the three
diagnostic methods using a chi-square test. Parasite densities
from microscopy readings (BS1 and BS2, or BS1 and BS2/
BS3) were averaged to get mean variable for microscopy re-
sults (here referred to as BSsum). Chi-squared test assessed
differences in proportion of positive tests by district. Cross
tabulations between tests results were used to estimate each
method’s sensitivity, specificity, positive and negative pre-
dictive values for RDT, taking BSsum and qPCR1 as gold
standard. McNemar’s test was used to assess the difference
in proportion of positive results by type of test. Kappa statis-
tic was used to quantify the strength of the tests’ results
agreement.Ethical clearance
The study protocol was determined to be exempt from eth-
ical review by CDC and received IHI ethical approval num-
ber IHI/IRB/No. A 73–2009 as well as a national ethical
permit from the Tanzanian National Institute for Medical
Research: NIMR/HQ/R.8a/Vol. IX/1534. The sample trans-
portation (import/ export) permit certificate No. 00007867,
dated September 1st, 2010, was issued by the Tanzania Pri-
vate Health Laboratories Board to allow movement of DNA
aliquots to CDC laboratory in Atlanta, GA, USA.
Verbal agreements to use patients’ level data for this
analysis were acquired at the district health management
level when permission was granted to conduct this study
in the selected health facilities. No personal identifiers
were used for patient’s data.Results
A total of 2,369 samples were collected from patients who
attended participating health facilities and 2,324 (98%)
samples had complete information. During data entry, 487
(20.9%) BS and/or DBS samples were found to have dupli-
cate IDs due to a printing error of specimen labels. In
addition, BS and DBS samples from 129 and 333 partici-
pants, respectively, were not collected which further re-
duced the number of available samples for microscopy
and PCR analysis. Removal of these duplicates and missing
samples left 1839 RDT samples, 1710 BS1, 1650 BS2 and
1506 DBS samples ready for analysis (Table 1). Sixty
(3.5%) slides with BS1 results could not be reviewed by the
second reader (BS2) due to poor quality of smears and
transportation challenges such as breakage.
Table 1 Summary of all samples collected from 12 health facilities, in Iringa and Mufindi District Councils (DC)
District Name of Health facility Expected samples Total RDT Total BS1 Total BS2 Total DBS
Iringa DC Idodi Health Center 200 164 164 164 161
Iringa DC Ifunda Dispensary 200 196 195 196 156
Iringa DC Ilambilole Dispensary 200 185 180 170 156
Iringa DC Kimande Health Center 200 195 158 194 166
Iringa DC Tosamaganga Hospital 200 158 88 109 115
Iringa DC Mlowa Dispensary 200 160 156 156 158
Mufindi DC Igomaa Dispensary* 200 92 92 91 91
Mufindi DC Kibao VA Health Center** 200 154 154 154 76
Mufindi DC Mafinga Hospital 200 161 161 142 118
Mufindi DC Malangali Health Center** 200 152 140 55 101
Mufindi DC Sadani Health Center* 200 60 60 60 59
Mufindi DC Usokami Health Center 200 162 162 159 149
Total 2400 1839 1710 1650 1506***
* Some samples had identical unique ID’s, hence removed from the analysis.
** Some samples were not sent for reference reading and/ or further analysis in Dar es Salaam.
*** DBS were not available from every sample.
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positive (Table 2). The local district microscopy (BS1)
found 50 out of 1,710 (2.9%) positives; reference micros-
copy (BS2) found 42 out of 1,650 (2.5%) positives and
qPCR1 found 64 out of 1,506 (4.2%) positives (Table 2).
Fifteen out of the 64 qPCR1 positive samples had a para-
site density of <200 parasites/μL and were not included
in further comparative analysis with RDT and BS results.
Malaria RDT had a higher overall positivity rate than
microscopy and qPCR1, even when stratified by district
(Table 2). The prevalence of malaria was found to be
higher in Iringa District by both microscopy (BSsum)
and qPCR1, but not by RDT which demonstrated higher
positivity in Mufindi District (Table 2).
Overall, the sensitivity of RDTs was 85.3% and 65.3%
with microscopy (BSsum) and qPCR1 used as the gold
standard, respectively. The predictive value positive of
RDT was very low by both microscopy (BSsum, 31.5%)
and qPCR1 (33.3%) (Table 3). RDT results were poorly
correlated with both microscopy BS1 (K = 0.50), BS2 (K =
0.43) and qPCR1 (K = 0.45) results (Table 4). MicroscopyTable 2 Number tested and number positive according to dia




Tested Positive (%) Tested Po
RDT 1839 120 (6.5) 1092 62 (5
BS1 1710 50 (2.9) 941 34 (3.6
BS2 1650 42 (2.5) 989 33 (3.3
BS-sum 1555 34 (2.2) 933 29 (3.1
qPCR1 1506 64 (4.2) 912 55 (6.0
*Chi-square test comparing district-level results.results between the local district (BS1) and reference
laboratories (BS2) showed 98.6% concordance (McNemar
test) and a high inter-observer agreement (K = 0.75,
p = 0.05) between them. Of the 300 DNA samples proc-
essed by qPCR2, 270 samples had satisfactory results. The
qPCR1 and qPCR2 results had 88.2% concordance, but
were poorly correlated (K = 0.32, p < 0.01).
Processing of BS1 took an average of 8 days (range = 1–
30 days), while that of BS2 averaged 36 days (range = 16–90
days). Significant delays (sometimes up to months) were ob-
served in processing and obtaining qPCR1 results, due to
technical challenges including equipment breakdown, lack
of in-country expertise to repair the apparatus necessitating
shipment to South Africa and short shelf-life of reagents.
Discussion
The aim of this study was to determine which of two
methods, local qPCR (qPCR1) or microscopy (BS1), would
provide optimal QA for RDTs in routine care. Neither of
the two QA methods investigated correlated very well with
RDT results, implying that these two tests (as performedgnostic test performed on specimens obtained from
strict Councils (DC)
Mufindi DC
P value*sitive (%) Tested Positive (%)
.7) 747 58 (7.7) 0.07
) 769 16 (2.1) 0.11
) 661 9 (1.4) 0.025
) 622 5 (0.8) 0.002
) 594 9 (1.5) <0.001
Table 3 RDT sensitivity, specificity and predictive values*
reference standard test; PPV = positive predictive value;
NPP = negative predictive value
Test combination (n) Sensitivity Specificity PPV NPV
RDT/ BS-sum* (1555) 85.3% 95.8% 31.5% 99.7%
RDT/ qPCR1* (1506) 65.3% 95.6% 33.3% 98.8%
*Reference standard test; PPV= positive predictive value; NPP= negative
predictive value.
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tations of RDTs and/or of the RDT performer may cause
inaccurate RDT test results. For example, RDTs are known
to detect persistent HRP-2 antigen even after the success-
ful treatment of malaria and clearance of asexual parasites
[8,24,25]. The presence of circulating antinuclear anti-
bodies such as in patients with rheumatoid arthritis, al-
though a rare occurrence, has also been shown to give
false positive RDT results [24,26]. In addition, studies in
other malaria endemic areas have associated false positiv-
ity of RDTs with presence of gametocytes in blood [27]
and acute schistosomiasis [28]. These other issues were
not investigate in this study, but the higher positivity ob-
served with RDT as compared to the other two tests can
be partly explained by the detection of persisting HRP-2
antigen.
Other factors known to lead to false positivity by RDTs in-
clude inappropriate testing procedures (e.g., substituting test
kit buffer solution with other liquids such as normal saline,
distilled water, tap water or buffer from different kits/lots/
batches) [29]. Incorrect reading of RDT results by health
workers during RDT testing is also known to influence test
performance [3,30]. It is highly likely that health worker per-
formance played a role in our findings because there is no
other reason for RDT positivity rates to be higher in
Mufindi district when all other malaria test results (BS1,
BS2, qPCR1 and qPCR2) were lower in this district. Further-
more, community based surveys (through the Tanzania HIV
and Malaria Indicator Surveys) and health facility data (as
reported by District Health Information System 2) support
higher transmission in Iringa district council than Mufindi
district [31]. Although assessment of testing procedure
during sample collection and supervisory visits showed very
good adherence to the testing procedures it is also prone to
observation bias (Hawthorne effect), hence a need toTable 4 Proportion of agreements between mRDT and micros
and correlation)
Tests combination Observed agreement Expected agree
RDT- BS1 (n = 1710) 95.6% 91.2%
RDT – BS2 (n = 1650) 95.2% 91.5%
RDT – qPCR1 (n = 1506) 94.9% 90.7%
BS1 - BS2 (n = 1508) 98.6% 94.5%
Kappa statistic*: p < 0.01.emphasize continued supportive supervision from health
managers. False negative RDT results due to prozone effect
have been reported [32]; however, there were no observed
correlation between very high parasite density as detected
by qPCR1 and microscopy with negative RDT results.
Studies have shown that the sensitivity of RDT compared
to PCR and microscopy decline sharply at low parasite dens-
ities [9,33], therefore, care must be taken when comparing
RDT results with molecular based diagnostic methods. The
qPCR assay used in this study was selected on the basis that
we would be able to quantify parasite densities and limit the
comparison to RDT expected threshold of detection [8]. In
this study, 15 qPCR1 positive samples had parasitemia of
less than 200 parasites/μL and only two of these were de-
tected as positive by RDT. Despite excluding these samples,
we did not observe good correlation between RDT and
qPCR1 unlike previous studies where high agreement be-
tween RDTand PCR [33-35] was reported.
Prompt responsiveness to problems with the quality of
RDTs will ensure timely remedial strategies such as
recalling defective RDT, providing refresher training to
laboratory staff, or implementing closer supervision and
follow-ups. This level of performance can only be prac-
tical where there is timely reporting of results to allow
effective feed back into the system. Therefore, the timeli-
ness of a QA test is an important consideration when
selecting an appropriate QA test. The average micros-
copy processing time observed in this study was eight
(8) days for district health facilities and 36 days at the
reference laboratory. The lower end of this duration (i.e.,
8 days) may be acceptable for use in routine QA, but im-
provement is needed to shorten this time to a fewer
number of days.
The significant delays we observed in sample processing
via qPCR1 and the fact that it was poorly correlated with
qPCR2 suggest that this may not be a suitable method of
QA in this setting. However, newer and simpler molecular
assays that can overcome this limitation may provide good
alternatives. This may include assays such as the loop medi-
ated isothermal amplification (LAMP) assays [36] and
Photo-induced Electron Transfer-PCR (PET-PCR) [37] that
have shown to work in similar settings. The LAMP assay
appears to be the most promising because of its simplicity,
rapid turn around and sensitivity [38]. The potential of usingcopy and qPCR (McNemar comparison, Kappa statistic
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lar analysis to monitor RDT performance in the field [39]
should be further explored in different settings, keeping in
mind the differences in detection limits of the two tests.
The importance of in-service training was clear in this
study. All technicians were trained in microscopy before
the study and the level of technical competence shown
by the districts’ microscopists in this study, to stain and
read slides, was encouraging. A good agreement between
health facility and reference laboratory microscopy re-
sults was observed. This was a great improvement com-
pared to previous result which demonstrated lack of
competence in health facility microscopy [9]. The fact
that microscopy is technically less challenging than
qPCR and that the performance shown by the districts’
technicians was better correlated with the reference mi-
croscopists after training, demonstrates the practicality
of using microscopy-based QA for monitoring perform-
ance of RDTs in routine care as previously indicated
[40]. However, the lack of agreement with RDT in this
study in addition to the long delays observed in obtain-
ing microscopy results brings to question the use of
microscope as a QA test for RDTs.
The new WHO guidelines for quality control of RDT in
field use are focused on quarterly supportive supervision
of RDT performers with assessment of the testing proced-
ure in clinical settings [39]. This intense level of quality
control at health facility level requires dedicated teams of
supervisors who will visit the health facilities and perform
the necessary assessment and provide the appropriate cor-
rective action to address noted deficiencies. Poor supervi-
sion and adherence to procedures may result in poor
quality RDT results, as previously reported in other parts
of Tanzania [41]. The use of positive control wells which
consist of lyophilized recombinant proteins (mainly HRP-
2) which can be reconstituted in the field and used to test
the correct performance of RDTs has been recommended
[42]. An alternative to this is the proposed use of well-
standardized P. falciparum - infected dried blood samples
in a tube that can also be used as positive control samples
for monitoring RDT performance [43].Conclusions
As highlighted in this study, finding an appropriate QA
strategy for RDTs is challenging given the many possible
factors that can compromise results from both the RDT
and the selected QA test. Ensuring performer supervision
in combination with the use of positive control samples to
ascertain RDT performance is likely to provide the most
practical and measureable QA approach for RDTs.Competing interests
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